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CYCLOSPORINE (CyA) is a highly 
metabolized cyclic peptide with potent 
immunosuppressive properties. Although the 
parent compound of Cy A is considered to be 
primarily responsible for the immunosuppres-
sive activity, initial observations with purified 
metabolite obtained by synthesis or by recov-
ery from animal studies suggests that metabo-
lites M 17, M 1, and M21 have immunosup-
pressant activity in vitro. I Human bile 
contains multiple CyA metabolites.2 and the 
contribution of its metabolites to the overall 
immunosuppressive effect of the drug is as yet 
unknown. The objective of this study was 
therefore to (1) recover multiple fractions 
from human bile and (2) test their inhibitory 
effect on the growth of human lymphocytes in 
vitro. 
MATERIALS AND METHODS 
Metabolite Recovery 
Pooled bile was collected from the T tubes of adult 
patients who had undergone orthotopic liver transplanta-
tion. A fresh 50-mL aliquot of bile was extracted with 
ethyl ether in a separatory funnel, the ether layer was 
obtained, and ether was removed under reduced pressure. 
The residue was reconstituted with aqueous methanol and 
washed in a separatory funnel with n-hexane, and the 
hexane layer was discarded. The hexane wash was repeat-
ed, and the aqueous methanol was taken to dryness under 
reduced pressure. 
The high-pressure liquid chromatographic (HPLC) 
system consisted of a gradient of acetonitrile:water 
pumped through a 15-cm, 5-/Lm C 18 column (Supelco, 
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Bellefonte, PAl that was heated to 70°C. UV detection 
was performed at 214-nm wavelength. The complex gra-
dient was adjusted to give the optimal separation of the 
component peaks over a period of I 18 minutes. The 
residue from the extraction was reconstituted with metha-
nol, and the injection volume was adjusted to permit 
maximal injection with the best possible peak separation 
Component peaks were manually collected. the acetonl 
trile was removed, and the aqueous portion was lyophil' 
ized. Dry material from matched peaks of multiple injec-
tions was combined, and the identity of the material was 
confirmed as previously reported. 2 
Lymphocyte Proliferation Studies 
Human peripheral blood lymphocytes were isolated 
from heparinized blood by the Ficoll-Hypaque technique. 
The lymphocytes (l05/ well) were incubated at 37°C in 
200 /LL tissue culture medium (TCM) supplemented with 
10% human serum in the presence of concanavalin A 
(Con A, 10 /Lg/mL) for 72 hours. During the final 20 
hours of incubation. each culture was labeled with I /LCi 
lH-thymidine. The cultures were harvested and counted 
in a liquid scintillation counter as previously described. 
Unidirectional human mixed lymphocyte reactlll 
(MLR) cultures were set up with 10' irradiated (2,000 R J 
stimulator cells in a volume of 200 /LL TCM supple-
mented with 10% human serum for six days. Proliferation 
was assessed by the degree of lH-thymidine incorporation 
during the final 20 hours of incubation. The inhibitory 
effects of Cy A and bile-derived metabolite fractions on 
Con A and MLR reactivity were measured at concentra-
tions ranging from 0.005 to 5.0 jlg/mL. The results are 
expressed as percent inhibition or (I - [cpm drug/cpm 
control]) x 100. 
RESULTS 
Thirteen major fractions were collected 
from the HPLC column, lyophilized, and 
combined with matched peaks to yield dry 
weights of between 0.65 and 2.41 mg. Figure i 
demonstrates an HPLC chromatogram of the 
injection of bile extract, the identification of 
each fraction on the chromatogram. and the 
corresponding identity of the peaks in relation 
to the nomenclature of Maurer.4 After identi-
fication, further HPLC analysis demonstrated 
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Fig 1. An HPLC chromato-
gram of an injection of bile 
extract. Collected fractions are 
shown as are corresponding 
eyA metabolite designations. 
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that bile-derived MI, MI8. and M21 were 
>95o/r pure by peak areas. whereas bile-
der; ',ed M 17 contained approximately 10% of 
an unidentified compound. The 13 compo-
nents, including bile-derived M 17, M I, M 18. 
and M2I, were subjected to immunologic 
testing. 
In the test of inhibition with Con A-
induced proliferation of peripheral blood lym-
phocytes. greater than 80% inhibition was 
observed with CyA concentrations of 0.5 /-Lg/ 
mL or greater. Bile-derived M17. MI, and 
M21 produced approximately 60%.50%, and 
30% inhibition at the highest concentration (5 
ILg/mL). but no effect was noted in any of 
the~e fractions at 0.05 ILg/mL or lower. The 
san.c ievel of 50% inhibition of the Con A-
stimulated response was observed with CyA in 
a IOO-fold lower concentration (0.05 ILg/mL). 
Figure 2 shows the results of the MLR stud-
ies. Greater than 80% inhibition of the MLR 
was observed for Cy A at concentrations as low 
as 0.05 ILg/mL. Significant inhibition was 
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observed with fraction 4 (unidentified) and 
with bile-derived M13. M17. MI. and M21 at 
the highest (5.0 /-Lg/mL) concentration. Bile-
derived M 17 exhibited inhibitory action in the 
MLR similar to CyA even after the tenfold 
and 1 ,ODD-fold dilution. 
DISCUSSION 
CyA metabolites can be recovered from 
human bile and do have pharmacological 
activity when tested agianst in vitro lympho-
cyte cultures. Human bile contains many Cy A 
metabolites, a number of which are only now 
being identified. 5 Con A stimulation of 
peripheral blood lymphocytes was inhibited 
by several bile-derived metabolite fractions, 
with relative potency being CyA > M 17 > 
MI > M21 > MI8. Although five bile frac-
tions produced 40% or greater inhibition of 
the MLR in the 5.0 J,Lg/mL concentration, the 
activity of M 17 was particularly striking in 
that it paralleled the activity of CyA even in 
1 ,ODD-fold dilution. This observation is partic-
0+------0----......::"-8'-----· Fig 2. Percent inhibition of an MLR v 
concentration of CyA. its metabolites. and 
a fraction ("4) from the HPLC collection. 
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ularly important in that M 17 frequently is 
found in the blood of transplant patients in 
equal or greater concentrations than CyA. 
Although the exact contribution of the metab-
BURCKART ET ;. 
olites to overall immunosuppressant activity is 
unclear, future studies of the action of CyA 
must take into account the presence of M 17 
and other metabolites. 
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